United States· US:73590-0052_a37811f9-7dfb-40f4-e053-2a95a90aa1f6
XYCOS PINK COLLAGENCREAM
A medicinal product containing adenosine; niacinamide, registered in United States by NOKSIBCHO cosmetic Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ADENOSINE; NIACINAMIDE
- Manufacturer
- NOKSIBCHO cosmetic Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11735900052150 mL in 1 BOTTLE (73590-0052-1)
- ndc1173590-0052-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/22c01325-9d29-4eab-8003-d5ed80201ebf GET /v1/drugs/22c01325-9d29-4eab-8003-d5ed80201ebf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".04; 2",
"substance": "ADENOSINE; NIACINAMIDE",
"productndc": "73590-0052",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/100mL; g/100mL",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about adenosine; niacinamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.